McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Saama Unveils Industry-first AI-Powered Tables, Listings, and Figures (TLF) Analyzer to Transform Clinical Study Reporting

by McKesson Ventures | Oct 30, 2025 | Press Releases

AI-driven life science services and solutions company Saama recently announced the launch of its Tables, Listings, and Figures (TLF) Analyzer — a system that uses Saama’s AI-powered document generation and multi-modal GenAI models to interpret and summarize complex...

Saama Introduces Modular and Adaptive AI Agents For Clinical Innovation

by McKesson Ventures | Sep 29, 2025 | Press Releases

AI-driven solutions and services provider Saama has announced the introduction of Clinical AI Agents — a modular, industry-first approach to rapidly increase innovation and efficiency for existing platform investments. These Clinical Agents, developed using Saama’s...

Saama Redefines the Future of Clinical Development with Groundbreaking GenAI and Collaborative Platform Enhancements

by McKesson Ventures | Jan 22, 2024 | Press Releases

On Monday, January 22nd, life science solutions company Saama announced a variety of new additions to its AI-based platform. The new features include the release of generative AI chat, interactive review listings, and an increased prioritization of cross-functional...

Biopharma Industry Leaders Ian Read and Clive Meanwell Join Saama Board of Directors

by McKesson Ventures | Nov 19, 2021 | Press Releases

The Saama Board of Directors recently gained some highly respected leaders in Ian Read, former CEO and executive chairman of Pfizer, and Clive Meanwell, former CEO and founder of The Medicines Company. This news was revealed after a $430 million strategic investment...

Carlyle and Leading Healthcare-Focused Venture Finds Announce Strategic Growth Investment of up to $430 Million in Saama

by McKesson Ventures | Oct 20, 2021 | Press Releases

Saama Technologies announced that funds led by global investment firm Carlyle have made a strategic growth investment and will acquire a majority stake in the company. A broad co-investor group with several healthcare-focused venture funds including Amgen Ventures,...

Recent Posts

  • Latent Raises $80M to Close the Gap Between Diagnosis and Treatment
  • Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
  • Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings